WOLFGANG WINKELMAYER to Drug Prescriptions
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Drug Prescriptions.
Connection Strength
0.918
-
Potential effects of the new Medicare Prospective Payment System on drug prescription in end-stage renal disease care. Blood Purif. 2011; 31(1-3):66-9.
Score: 0.322
-
Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1401-1412.
Score: 0.117
-
Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2016 Jan; 25(1):90-9.
Score: 0.112
-
Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
Score: 0.088
-
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2662-8.
Score: 0.084
-
Angiotensin inhibition after myocardial infarction: does drug class matter? J Gen Intern Med. 2006 Dec; 21(12):1242-7.
Score: 0.060
-
Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
Score: 0.056
-
How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf. 2004 Jan; 13(1):11-9.
Score: 0.049
-
Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. J Am Soc Nephrol. 2016 Oct; 27(10):3129-3138.
Score: 0.029